Medline (MDLN) Leases (2024 - 2025)

Medline (MDLN) reported Leases of $432.0 million for Q4 2025, up 12.5% year-over-year from $384.0 million in Q4 2024, and up 12.5% quarter-over-quarter from $384.0 million in Q4 2024.

Medline (MDLN) Leases (2024 - 2025) Analysis & Trends

Medline (MDLN) has 2 years of Leases data on file, last reported at $432.0 million in Q4 2025.

  • Leases for Q4 2025 came in at $432.0 million, up 12.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $432.0 million (up 12.5% YoY), and the FY2025 annual result was $432.0 million, up 12.5% from the prior year.
  • Leases rose to $432.0 million in Q4 2025 per MDLN's latest filing, from $384.0 million in the prior quarter.
  • Over five years, Leases peaked at $432.0 million in Q4 2025 and troughed at $384.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Intuitive Surgical 145.76 Bn 141.37 Bn 1.83 Bn -
2 Becton Dickinson 41.48 Bn 40.47 Bn 2.15 Bn -
3 Medline 29.98 Bn 35.82 Bn 1.84 Bn -
4 Resmed 28.25 Bn 26.59 Bn 890.98 Mn 161.60 Mn
5 West Pharmaceutical Services 23.60 Bn 23.08 Bn 296.40 Mn 110.20 Mn
6 Solventum 13.72 Bn 13.72 Bn 1.10 Bn 207.00 Mn
7 Cooper Companies 13.23 Bn 13.10 Bn 735.40 Mn -
8 Align Technology 12.49 Bn 11.43 Bn 736.59 Mn 110.22 Mn
9 Baxter International 10.74 Bn 8.69 Bn 891.00 Mn 277.00 Mn
10 Aptargroup 7.53 Bn 7.32 Bn 351.91 Mn 61.23 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 432.00 Mn
Dec 31, 2024 384.00 Mn